<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">850058</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2022.850058</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Variants of MicroRNA and DROSHA Genes in Association With the Risk of Tuberculosis in the Amazon Population</article-title>
<alt-title alt-title-type="left-running-head">Leal et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Genetic Variants and Tuberculosis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Leal</surname>
<given-names>Diana Feio da Veiga Borges</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1626019/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santana da Silva</surname>
<given-names>Mayara Nat&#x00E1;lia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672793/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pastana</surname>
<given-names>Lucas Favacho</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1673009/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fernandes</surname>
<given-names>Marianne Rodrigues</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672761/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Athayde</surname>
<given-names>Aidalucy do Socorro Costa de</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672857/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernandes Porchera</surname>
<given-names>D&#xe9;bora Christina Ricardo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672751/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Cleonardo Augusto da</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672861/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Modesto</surname>
<given-names>Ant&#xf4;nio Andr&#xe9; Conde</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672797/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Assumpc&#xe3;o</surname>
<given-names>Paulo Pimentel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/668719/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Sidney Emanuel Batista dos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1020426/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Ney Pereira Carneiro dos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/849421/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>N&#xfa;cleo de Pesquisa em Oncologia</institution>, <institution>Universidade Federal do Par&#xe1;</institution>, <addr-line>Bel&#xe9;m</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laborat&#xf3;rio de Gen&#xe9;tica Humana e M&#xe9;dica</institution>, <institution>Instituto de Ci&#xea;ncias Biol&#xf3;gicas</institution>, <institution>Universidade Federal do Par&#xe1;</institution>, <addr-line>Bel&#xe9;m</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/987650/overview">Aftab Ali Shah</ext-link>, University of Malakand, Pakistan</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/933141/overview">Balint Nagy</ext-link>, University of Debrecen, Hungary</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/84869/overview">Afsoon Afshari</ext-link>, Shiraz University of Medical Sciences,&#x20;Iran</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Marianne Rodrigues Fernandes, <email>fernandesmr@yahoo.com.br</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to RNA, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>850058</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Leal, Santana da Silva, Pastana, Fernandes, Athayde, Fernandes Porchera, Silva, Modesto, De Assumpc&#xe3;o, Santos and Santos.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Leal, Santana da Silva, Pastana, Fernandes, Athayde, Fernandes Porchera, Silva, Modesto, De Assumpc&#xe3;o, Santos and Santos</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Tuberculosis (TB) is a chronic infection caused by <italic>Mycobacterium tuberculosis</italic> (Mtb) with high incidence and mortality. Studies reported that host genetic variants might be associated with the risk of tuberculosis. The aim of this study was to perform an association study between 26 single nucleotide polymorphisms (SNPs) and tuberculosis and evaluate whether these SNPs may confer risk factors to tuberculosis in the Amazon population. There were 52 males and 126 females, with total of 178 healthy controls. Genotyping was performed using TaqMan Open Array Genotyping. Ancestry-informative markers were used to estimate the ancestral proportions of the individuals in the case and control groups. The results indicated that the SNPs rs10035440 (DROSHA), rs7372209 (miR26-a1), rs1834306 (miR100), rs4919510 (miR608), and rs10739971 (pri-let-7a-1) were significantly associated with high risk and rs3746444 (miR499) and rs6505162 (miR423), with low risk of developing tuberculosis in the Amazon population. Our study concluded that seven miRNA polymorphisms were associated with tuberculosis. Our study contributes to a better understanding of TB pathogenesis and may promote the development of new diagnostic tools against <italic>M. tuberculosis</italic> infection.</p>
</abstract>
<kwd-group>
<kwd>genetic variants</kwd>
<kwd>microRNA</kwd>
<kwd>drosha</kwd>
<kwd>tuberculosis</kwd>
<kwd>risk factor</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Tuberculosis (TB) is a chronic infection caused by <italic>Mycobacterium tuberculosis</italic> (Mtb), and it remains one of the most serious infections with high incidence and mortality, mostly in developing countries. According to the World Health Organization (WHO) report, there were an estimated number of 10 million new TB cases and 1.4 million deaths worldwide in 2019 (<xref ref-type="bibr" rid="B35">WHO 2020</xref>).</p>
<p>Early detection and appropriate treatment are the most important control strategy for TB. However, there is a low rate of TB cases detected and officially notified. In addition, smear microscopy and culture are the &#x201c;gold standards&#x201d; for the diagnosis of TB; however, faster and more sensitive diagnostic tests are required to improve diagnosis and patient management during infection (<xref ref-type="bibr" rid="B1">Acharya et&#x20;al., 2020</xref>).</p>
<p>Emerging evidence suggests that miRNAs might be involved in the pathogenesis of a variety of human diseases, including TB (<xref ref-type="bibr" rid="B25">Sabir et&#x20;al., 2018</xref>). MicroRNAs are an important regulator of biological processes, such as innate immune response against various infections (<xref ref-type="bibr" rid="B34">Wang and Cui 2012</xref>). They regulate the primary function of macrophages, dendritic cells, and natural killer cells (NKCs) and influence other regulation of proteins involved in the innate and adaptive immune pathways (<xref ref-type="bibr" rid="B26">Sahu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B31">Tamgue et&#x20;al., 2019</xref>).</p>
<p>Comparative miRNA expression profiles in individuals with active tuberculosis and healthy controls were studied in an Amazon population. Three different miRNA expressions, hsa-miR-4732-5p, hsa-miR-486-3p, and hsa-let-7g-5p, were identified in tuberculosis patients (<xref ref-type="bibr" rid="B29">Silva et&#x20;al., 2021</xref>). However, different miRNA expressions can vary between individual samples during treatment and recovery (<xref ref-type="bibr" rid="B12">Kleinsteuber et&#x20;al., 2013</xref>).</p>
<p>Recently, genetic variants in IL10, VDR, and microRNA genes were reported in subsequent studies in different human populations. However, there were few results of the association between these microRNA polymorphisms and tuberculosis susceptibility (<xref ref-type="bibr" rid="B30">Song et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B28">Silva et&#x20;al., 2020</xref>). The aim of this study was to perform an association study between SNPs in miRNA and DROSHA and tuberculosis and evaluate whether these selected SNPs may confer susceptibility or protection to TB in the Amazon population.</p>
</sec>
<sec id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Subjects</title>
<p>There were 52 males and 126 females, with total of 178 healthy controls in the Amazon population. The subjects enrolled in the case group were individuals diagnosed with active TB. The diagnosis of TB was based on clinical, radiological, sputum acid-fast bacillus (AFB) smear positivity, and/or culture. The patients were diagnosed with TB for a minimum of 6&#xa0;months in Hospital Jo&#xe3;o Barros Barreto in Bel&#xe9;m city (Par&#xe1;, Brazil). The control group was a special group with healthy individuals who were participants from a Geriatric Program in Hospital Jo&#xe3;o Barros Barreto in Bel&#xe9;m city (Par&#xe1;, Brazil), with a high probability to be in contact with TB disease. The study was approved by the Ethical Committee of Universidade Federal do Par&#xe1;, and all subjects gave written informed consent (protocol number: 42106720.2.0000.5634).</p>
</sec>
<sec id="s2-2">
<title>2.2 Single Nucleotide Polymorphism Selection</title>
<p>A total of 26 single nucleotide polymorphisms were selected based on previous reports of the marker in associative studies found in the Pubmed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">www.ncbi.nlm.nih.gov/</ext-link>) database. Most SNPs are related to biological processes, immune responses, tuberculosis, or infectious diseases.</p>
</sec>
<sec id="s2-3">
<title>2.3 DNA Extraction</title>
<p>Peripheral blood (8&#xa0;ml) from patients and healthy subjects was collected in EDTA-coated tubes. Genomic DNA from case and control groups was extracted from 200&#xa0;uL peripheral whole blood samples using the Mini Spin Plus Extraction Kit (BioPur, Curitiba, Paran&#xe1;, BR), according to the manufacturer&#x2019;s instructions. The DNA samples were quantified by spectrophotometry at 260&#xa0;nm using the Nanodrop 2000 device (NanoDrop Technologies, Wilmington, DE, United&#x20;States). The purity of the analytes was evaluated through the ratio between absorbances obtained at the lengths of 260 and 280&#xa0;nm, thus evaluating the quality of the&#x20;DNA.</p>
</sec>
<sec id="s2-4">
<title>2.4 Single Nucleotide Polymorphism Genotyping</title>
<p>The polymorphisms were genotyped by allelic discrimination using TaqMan Open Array technology in the QuantStudio&#x2122;12K Flex Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, United&#x20;States), according to the manufacturer&#x2019;s protocol. Data analysis was performed using the TaqMan<sup>&#xae;</sup> Genotyper Software package (Thermo Fisher Scientific, Waltham, MA, United&#x20;States).</p>
</sec>
<sec id="s2-5">
<title>2.5&#x20;Ancestry-Informative Markers</title>
<p>A panel of 61&#x20;ancestry-informative markers was used to estimate the ancestral proportions of an Amazon population described previously by <xref ref-type="bibr" rid="B27">Santos et&#x20;al. (2010)</xref> and expanded later by <xref ref-type="bibr" rid="B24">Ramos et&#x20;al. (2016)</xref>. Brazil is a country with a highly admixed population, composed mainly of Europeans, Africans, and Native Americans. We used this AIM panel that was composed of ancestry-specific markers that can estimate individual and population genetic contribution.</p>
</sec>
<sec id="s2-6">
<title>2.6 Statistical Analysis</title>
<p>Differences in baseline characteristics, including age, sex, and ancestry analysis, were compared using Fisher&#x2019;s exact and Mann&#x2013;Whitney tests. The associations between SNPs and TB were estimated by computing the odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression analyses, adjusted for sex and ancestry. ORs were defined concerning the case groups, i.e.,&#x20;ORs &#x3e;1 represent an increased risk of TB. A <italic>p</italic>-value &#x3c; 0.05 was considered statistically significant. Hardy&#x2013;Weinberg equilibrium (HWE) proportion tests with the Bonferroni correction were used to evaluate the quality of the genotype&#x20;data.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<p>There were 52 males and 126 females, with total of 178 healthy controls (mean age 70.82&#x20;&#xb1; 1.8&#xa0;years; 52 males and 126 females) were enrolled. Both significant differences were found in the distribution of age and sex between cases and healthy controls. The population structure results showed significant differences in European, Amerindian, and African contributions in the cases compared to controls. As expected, the population ancestry showed a higher Amerindian and African contribution and a lower European ancestry in the opposite direction in TB patients than that in controls (<xref ref-type="table" rid="T1">Table&#x20;1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Clinical characteristics and genetic ancestry of subjects.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Variable</th>
<th align="center">Case (<italic>n</italic>&#x20;&#x3d; 190)</th>
<th align="center">Control (<italic>n</italic>&#x20;&#x3d; 176)</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Age (years)</td>
<td align="center">51.8 (49.2&#x2013;54.4)</td>
<td align="center">70.82 (68.5&#x2013;72.1)</td>
<td align="char" char=".">&#x3c;0.001<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">Sex (male/female)</td>
<td align="center">88(46.3%)/102(53.7%)</td>
<td align="center">52(29.3%)/126(70.7%)</td>
<td align="char" char=".">0.001<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">EUR ancestry<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">0.25 (0.23&#x2013;0.27)</td>
<td align="center">0.45 (0.42&#x2013;0.48)</td>
<td align="char" char=".">&#x3c;0.001<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">AMR ancestry<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">0.42 (0.38&#x2013;0.43)</td>
<td align="center">0.31 (0.28&#x2013;0.32)</td>
<td align="char" char=".">&#x3c;0.001<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">AFR ancestry<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">0.33 (0.31&#x2013;0.35)</td>
<td align="center">0.24 (0.22&#x2013;0.26)</td>
<td align="char" char=".">&#x3c;0.001<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Mann&#x2013;Whitney&#x20;test.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>Fisher&#x2019;s exact Test.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>Multivariate regression logistic. Data are presented as median &#xb1;standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A total of 26 SNPs were tested for the Hardy&#x2013;Weinberg equilibrium with the Bonferroni correction (<xref ref-type="table" rid="T2">Table&#x20;2</xref>). In overall 26 SNPs, 10 markers were excluded for further analyses, and the remaining 16 SNPs were included for subsequent analysis by the Hardy&#x2013;Weinberg equilibrium (<xref ref-type="table" rid="T3">Table&#x20;3</xref>). The results indicated that seven SNPs showed a significant association with TB risk, and those SNPs were rs10035440 in DROSHA, rs7372209 in miR26-a1, rs1834306 in miR100, rs4919510 in miR608, rs10739971 in pri-let-7a-1, rs3746444 in miR499, and rs6505162 in miR423 (<xref ref-type="table" rid="T4">Table&#x20;4</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>All 26 SNPs in microRNA and DROSHA genes with Hardy-Weinberg equilibrium (HWE) tests with the Bonferroni correction.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene</th>
<th align="center">
<italic>p-value</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">DROSHA (rs639174)</td>
<td align="char" char=".">0.001</td>
</tr>
<tr>
<td align="left">DROSHA (rs10035440)</td>
<td align="char" char=".">0.787&#x2a;</td>
</tr>
<tr>
<td align="left">miR453 (rs56103835)</td>
<td align="char" char=".">0.817&#x2a;</td>
</tr>
<tr>
<td align="left">miR 2053 (rs10505168)</td>
<td align="char" char=".">0.109&#x2a;</td>
</tr>
<tr>
<td align="left">miR300 (rs12894467)</td>
<td align="char" char=".">1&#x2a;</td>
</tr>
<tr>
<td align="left">miR-146A (rs2910164)</td>
<td align="char" char=".">0.861&#x2a;</td>
</tr>
<tr>
<td align="left">miR196A2 (rs11614913)</td>
<td align="char" char=".">1&#x2a;</td>
</tr>
<tr>
<td align="left">miR149 (rs2292832)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">AGO01 (rs636832)</td>
<td align="char" char=".">0.850&#x2a;</td>
</tr>
<tr>
<td align="left">miR200B/200A/429 (rs9660710)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">miR20b/miR-17-5P (rs3660)</td>
<td align="char" char=".">0.022</td>
</tr>
<tr>
<td align="left">miR608 (rs4919510)</td>
<td align="char" char=".">0.125&#x2a;</td>
</tr>
<tr>
<td align="left">miR499 (rs3746444)</td>
<td align="char" char=".">0.204&#x2a;</td>
</tr>
<tr>
<td align="left">miR605 (rs2043556)</td>
<td align="char" char=".">0.003</td>
</tr>
<tr>
<td align="left">miR570 (rs4143815)</td>
<td align="char" char=".">0.008</td>
</tr>
<tr>
<td align="left">miR200C (rs12904)</td>
<td align="char" char=".">0.340&#x2a;</td>
</tr>
<tr>
<td align="left">pre-miR938 (rs2505901)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">pri-let-7a-1 (rs10739971)</td>
<td align="char" char=".">0.113&#x2a;</td>
</tr>
<tr>
<td align="left">miR219A1 (rs107822)</td>
<td align="char" char=".">0.211&#x2a;</td>
</tr>
<tr>
<td align="left">miR604 (rs2368392)</td>
<td align="char" char=".">0.002</td>
</tr>
<tr>
<td align="left">miR26-a1 (rs7372209)</td>
<td align="char" char=".">0.183&#x2a;</td>
</tr>
<tr>
<td align="left">miR100 (rs1834306)</td>
<td align="char" char=".">0.718&#x2a;</td>
</tr>
<tr>
<td align="left">miR219-1 (rs213210)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">miR4513 (rs2168518)</td>
<td align="char" char=".">0.073&#x2a;</td>
</tr>
<tr>
<td align="left">miR423 (rs6505162)</td>
<td align="char" char=".">1&#x2a;</td>
</tr>
<tr>
<td align="left">DROSHA (rs3805500)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Association analysis of 16 SNPS with risk of TB disease in accordance with the Hardy&#x2013;Weinberg equilibrium.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Genotype (SNP ID)</th>
<th align="center">Case (%)</th>
<th align="center">Control (%)</th>
<th align="center">
<italic>p-value</italic>
</th>
<th align="center">OR (95% CI)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">DROSHA (rs10035440)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 107</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 148</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">35 (33%)</td>
<td align="center">06 (04%)</td>
<td align="center">15.58 (5.04-48.15)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">72 (67%)</td>
<td align="center">44 (30%)</td>
<td rowspan="2" align="center">0.996</td>
<td rowspan="2" align="center">TT vs. CT &#x2b; CC<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">0 (0%)</td>
<td align="center">98 (66%)</td>
</tr>
<tr>
<td align="left">miR453 (rs56103835)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 75</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 142</td>
<td rowspan="2" align="center">0.322</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">09 (12%)</td>
<td align="center">07 (05%)</td>
<td align="center">1.80 (0.56&#x2013;5.77)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">33 (44%)</td>
<td align="center">54 (38%)</td>
<td rowspan="2" align="center">0.142</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">33 (44%)</td>
<td align="center">81 (57%)</td>
<td align="center">1.60 (0.85-3.00)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR 2053 (rs10505168)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 67</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 122</td>
<td rowspan="2" align="center">0.975</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">10 (15%)</td>
<td align="center">19 (15%)</td>
<td align="center">1.05 (0.39-2.58)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">29 (43%)</td>
<td align="center">47 (39%)</td>
<td rowspan="2" align="center">0.931</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">28 (42%)</td>
<td align="center">56 (46%)</td>
<td align="center">1.03 (0.52&#x2013;2.03)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR300 (rs12894467)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 146</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 141</td>
<td rowspan="2" align="center">0.266</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">17 (11%)</td>
<td align="center">20 (14%)</td>
<td align="center">1.56 (0.71-3.44)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">80 (55%)</td>
<td align="center">46 (33%)</td>
<td rowspan="2" align="center">0.654</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">49 (34%)</td>
<td align="center">75 (53%)</td>
<td align="center">1.12 (0.66&#x2013;1.90)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR146A (rs2910164)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 131</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 160</td>
<td rowspan="2" align="center">0.696</td>
<td align="center">GG &#x2b; CG vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">13 (10%)</td>
<td align="center">18 (11%)</td>
<td align="center">0.845 (0.36-1.96)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CG</td>
<td align="center">59 (45%)</td>
<td align="center">74 (46%)</td>
<td rowspan="2" align="center">0.590</td>
<td align="center">GG vs. CG &#x2b; CC</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">59 (45%)</td>
<td align="center">68 (43%)</td>
<td align="center">1.15 (0.67&#x2013;1.97)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR196A2 (rs11614913)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 96</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 145</td>
<td rowspan="2" align="center">0.634</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">50 (52%)</td>
<td align="center">65 (45%)</td>
<td align="center">1.15 (0.64-2.07)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">41 (43%)</td>
<td align="center">65 (45%)</td>
<td rowspan="2" align="center">0.239</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">05 (05%)</td>
<td align="center">15 (10%)</td>
<td align="center">1.98 (0.63&#x2013;6.18)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">AGO01 (rs636832)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 105</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 150</td>
<td rowspan="2" align="center">0.643</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">15 (14%)</td>
<td align="center">14 (09%)</td>
<td align="center">1.22 (0.51-2.90)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">45 (43%)</td>
<td align="center">67 (45%)</td>
<td rowspan="2" align="center">0.450</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">45 (43%)</td>
<td align="center">69 (46%)</td>
<td align="center">0.80 (0.45&#x2013;1.42)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR608 (rs4919510)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 116</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 161</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG &#x2b; CG vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">21 (18%)</td>
<td align="center">85 (53%)</td>
<td align="center">4.53 (2.30-8.92)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CG</td>
<td align="center">46 (40%)</td>
<td align="center">58 (36%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. CG &#x2b; CC</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">49 (42%)</td>
<td align="center">18 (11%)</td>
<td align="center">4.13 (2.25-7.60)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR499 (rs3746444)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 127</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 167</td>
<td rowspan="2" align="center">0.995</td>
<td rowspan="2" align="center">GG &#x2b; AG vs. AA<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">0 (0%)</td>
<td align="center">126 (75%)</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">31 (25%)</td>
<td align="center">36 (22%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">96 (75%)</td>
<td align="center">05 (3%)</td>
<td align="center">0.009 (0.003&#x2013;0.26)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR200C (rs12904)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 106</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 156</td>
<td rowspan="2" align="center">0.474</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">35 (33%)</td>
<td align="center">38 (24%)</td>
<td align="center">1.25 (0.67&#x2013;2.33)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">42 (39%)</td>
<td align="center">72 (46%)</td>
<td rowspan="2" align="center">0.717</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">29 (28%)</td>
<td align="center">46 (30%)</td>
<td align="center">1.12 (0.60-2.07)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">pri-let-7a-1 (rs10739971)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 91</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 83</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">70 (76.92%)</td>
<td align="center">32 (38%)</td>
<td align="center">6.14 (2.88-13.08)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">17 (18.68%)</td>
<td align="center">33 (40%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">4 (4.4%)</td>
<td align="center">18 (22%)</td>
<td align="center">7.25 (2.13-24.69)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR219-1(rs107822)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 90</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 152</td>
<td rowspan="2" align="center">0.528</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">50 (55%)</td>
<td align="center">85 (56%)</td>
<td align="center">1.20 (0.67&#x2013;2.17)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">33 (37%)</td>
<td align="center">53 (35%)</td>
<td rowspan="2" align="center">0.994</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">7 (8%)</td>
<td align="center">14 (9%)</td>
<td align="center">0.99 (0.34-2.87)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR26-a1 (rs7372209)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 113</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 145</td>
<td rowspan="2" align="center">0.752</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">49 (44%)</td>
<td align="center">70 (48%)</td>
<td align="center">0.91 (0.52-1.59)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">58 (51%)</td>
<td align="center">56 (39%)</td>
<td rowspan="2" align="center">0.017&#x2a;</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">6 (5%)</td>
<td align="center">19 (13%)</td>
<td align="center">3.75 (1.26&#x2013;11.15)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR100 (rs1834306)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 76</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 123</td>
<td rowspan="2" align="center">0.001&#x2a;</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">35 (46%)</td>
<td align="center">33 (27%)</td>
<td align="center">3.39 (1.67&#x2013;6.85)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">31 (41%)</td>
<td align="center">64 (52%)</td>
<td rowspan="2" align="center">0.128</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">10 (13%)</td>
<td align="center">26 (21%)</td>
<td align="center">1.99 (0.81-4.86)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR4513 (rs2168518)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 125</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 163</td>
<td rowspan="2" align="center">0.505</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">9 (7%)</td>
<td align="center">22 (13%)</td>
<td align="center">0.73 (0.29&#x2013;1.82)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">51 (41)</td>
<td align="center">61 (38%)</td>
<td rowspan="2" align="center">0.931</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">65 (52%)</td>
<td align="center">80 (49%)</td>
<td align="center">1.02 (0.60-1.73)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR423 (rs6505162)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 77</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 124</td>
<td rowspan="2" align="center">0.021&#x2a;</td>
<td align="center">CC &#x2b; AC vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">8 (10%)</td>
<td align="center">30 (24%)</td>
<td align="center">0.33 (0.13&#x2013;0.84)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AC</td>
<td align="center">52 (68%)</td>
<td align="center">62 (50%)</td>
<td rowspan="2" align="center">0.449</td>
<td align="center">CC vs. AC &#x2b; AA</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">17 (22%)</td>
<td align="center">32 (26%)</td>
<td align="center">1.34 (0.62-2.90)<sup>b</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>
<italic>p</italic>-values for logistic analyses of alternative models (dominant <sup>a</sup> and recessive <sup>b</sup> models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Association analysis of seven significant SNPs with the risk of TB disease.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Genotype (SNP ID)</th>
<th align="center">Case (%)</th>
<th align="center">Control (%)</th>
<th align="center">
<italic>p-value</italic>
</th>
<th align="center">OR (95% CI)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">DROSHA (rs10035440)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 107</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 148</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">35 (33%)</td>
<td align="center">06 (04%)</td>
<td align="center">15.58 (5.04-48.15)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">72 (67%)</td>
<td align="center">44 (30%)</td>
<td rowspan="2" align="center">0.996</td>
<td rowspan="2" align="center">TT vs. CT &#x2b; CC <sup>b</sup>
</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">0 (0%)</td>
<td align="center">98 (66%)</td>
</tr>
<tr>
<td align="left">miR608 (rs4919510)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 116</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 161</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG &#x2b; CG vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">21 (18%)</td>
<td align="center">85 (53%)</td>
<td align="center">4.53 (2.30-8.92)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CG</td>
<td align="center">46 (40%)</td>
<td align="center">58 (36%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. CG &#x2b; CC</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">49 (42%)</td>
<td align="center">18 (11%)</td>
<td align="center">4.13 (2.25-7.60)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR499 (rs3746444)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 127</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 167</td>
<td rowspan="2" align="center">0.995</td>
<td rowspan="2" align="center">GG &#x2b; AG vs. AA<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">0 (0%)</td>
<td align="center">126 (75%)</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">31 (25%)</td>
<td align="center">36 (22%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">96 (75%)</td>
<td align="center">05 (3%)</td>
<td align="center">0.009 (0.003&#x2013;0.26)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">pri-let-7a-1 (rs10739971)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 91</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 83</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">70 (76.92%)</td>
<td align="center">32 (38%)</td>
<td align="center">6.14 (2.88-13.08)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">17 (18.68%)</td>
<td align="center">33 (40%)</td>
<td rowspan="2" align="center">&#x3c;0.001&#x2a;</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">4 (4.4%)</td>
<td align="center">18 (22%)</td>
<td align="center">7.25 (2.13-24.69)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR26-a1 (rs7372209)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 113</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 145</td>
<td rowspan="2" align="center">0.752</td>
<td align="center">TT &#x2b; CT vs. CC</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">49 (44%)</td>
<td align="center">70 (48%)</td>
<td align="center">0.91 (0.52-1.59)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">CT</td>
<td align="center">58 (51%)</td>
<td align="center">56 (39%)</td>
<td rowspan="2" align="center">0.017&#x2a;</td>
<td align="center">TT vs. CT &#x2b; CC</td>
</tr>
<tr>
<td align="left">TT</td>
<td align="center">6 (5%)</td>
<td align="center">19 (13%)</td>
<td align="center">3.75 (1.26&#x2013;11.15)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR100 (rs1834306)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 76</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 123</td>
<td rowspan="2" align="center">0.001&#x2a;</td>
<td align="center">GG &#x2b; AG vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">35 (46%)</td>
<td align="center">33 (27%)</td>
<td align="center">3.39 (1.67&#x2013;6.85)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AG</td>
<td align="center">31 (41%)</td>
<td align="center">64 (52%)</td>
<td rowspan="2" align="center">0.128</td>
<td align="center">GG vs. AG &#x2b; AA</td>
</tr>
<tr>
<td align="left">GG</td>
<td align="center">10 (13%)</td>
<td align="center">26 (21%)</td>
<td align="center">1.99 (0.81-4.86)<sup>b</sup>
</td>
</tr>
<tr>
<td align="left">miR423 (rs6505162)</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 77</td>
<td align="center">
<italic>n</italic>&#x20;&#x3d; 124</td>
<td rowspan="2" align="center">0.021&#x2a;</td>
<td align="center">CC &#x2b; AC vs. AA</td>
</tr>
<tr>
<td align="left">AA</td>
<td align="center">8 (10%)</td>
<td align="center">30 (24%)</td>
<td align="center">0.33 (0.13&#x2013;0.84)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left">AC</td>
<td align="center">52 (68%)</td>
<td align="center">62 (50%)</td>
<td rowspan="2" align="center">0.449</td>
<td align="center">CC vs. AC &#x2b; AA</td>
</tr>
<tr>
<td align="left">CC</td>
<td align="center">17 (22%)</td>
<td align="center">32 (26%)</td>
<td align="center">1.34 (0.62-2.90)<sup>b</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>
<italic>p</italic>-values for logistic analyses of alternative models (dominant <sup>a</sup> and recessive <sup>b</sup> models) are shown. Multivariate logistic regression with sex and ancestry is used as covariates. Genotypic frequency distributions are in accordance with the Hardy&#x2013;Weinberg equilibrium (HWE, <italic>p</italic>&#x20;&#x3e; 0.05).</p>
</table-wrap-foot>
</table-wrap>
<p>The results of the genotype distribution showed that the SNPs rs10035440 (DROSHA) and rs1834306 (miR100) were associated with an increased risk of TB (OR &#x3d; 15.58, 95% CI [5.04-48.15] and OR &#x3d; 3.39, 95% CI [1.67&#x2013;6.85], respectively) in the dominant model. The SNP rs7372209 (miR26-a1) was associated with an increased risk of TB in a recessive model (OR &#x3d; 3.75, 95% CI [1.26&#x2013;11.15]).</p>
<p>In addition, the SNPs rs4919510 (miR608) and rs10739971 (pri-let-7a-1) were associated with an increased risk of TB in dominant and recessive models. The SNP rs4919510 was associated with an increased risk of TB in the analysis of the dominant model (OR &#x3d; 4.53, 95% CI [2.30&#x2013;8.92]) and in the analysis of the recessive model (OR &#x3d; 4.13, 9&#x20;5% CI [2.25&#x2013;7.60]). The SNP rs10739971 was associated with an increased risk of TB in the analysis of the dominant model (OR &#x3d; 6.14, 95% CI [2.88&#x2013;13.08]) and in the analysis of the recessive model (OR &#x3d; 7.25, 95% CI [2.13&#x2013;24.69]).</p>
<p>However, the SNPs rs3746444 and rs6505162 were associated with a low risk of TB in the analysis of the recessive model (OR &#x3d; 0.009, 95% CI [0.003&#x2013;0.26]) and rs6505162, in the analysis of the dominant model (OR &#x3d; 0.33, 95% CI [0.13&#x2013;0,84]).</p>
</sec>
<sec id="s4">
<title>4 Discussion</title>
<p>In the present study, we examined the possible association of polymorphisms in miRNA and DROSHA genes with tuberculosis susceptibility in the Brazilian Amazonian population. There were 52 males and 126 females, with total of 178 healthy controls. According to our results, we found seven SNPs in different genes that were associated with TB susceptibility. However, there are relatively few reports regarding the association of genetic variants and susceptibility to tuberculosis in an admixture of population such as the Brazilian Amazonian population.</p>
<p>Our previous study investigated the effect of ancestral background on TB susceptibility among the Brazilian Amazonian population. The results indicated that Amerindian (compared to African and European) ancestry populations were significantly associated as a risk factor for susceptibility to TB in the Brazilian Amazonian population (<xref ref-type="bibr" rid="B14">Leal et&#x20;al., 2020</xref>). In the present study, we used ancestry-informative markers (AIMs) to estimate genetic ancestry and control for stratification to investigate genetic association among Brazilian admixed populations.</p>
<p>Our results suggested that the SNPs rs10035440 (DROSHA), rs4919510 (miR608), rs10739971 (pri-let-7a-1), rs7372209 (miR26-a1), and rs1834306 (miR100) were associated to an increased risk of TB. With respect to SNPs rs3746444 (miR499) and rs6505162 (miR423), these genetic variants were associated to a decreased risk for TB susceptibility in active-TB patients.</p>
<p>Previous studies have revealed that deregulation of miRNAs and miRNA-related genes occur in many diseases (<xref ref-type="bibr" rid="B5">de Souza et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B28">Silva et&#x20;al., 2020</xref>). DROSHA initiates the biosynthesis of miRNAs by processing pri-miRNAs. Single nucleotide polymorphisms (SNPs) in miRNA biosynthesis genes, DROSHA, were indicated to be correlated with cancer risk as pediatric ALL (<xref ref-type="bibr" rid="B8">Gutierrez-Camino et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B18">L&#xf3;pez-L&#xf3;pez et&#x20;al., 2014</xref>).</p>
<p>Some studies suggested that genetic variations were associated with cancer, HBV infection, and sepsis. <xref ref-type="bibr" rid="B4">Dai et&#x20;al. (2018)</xref> reported that the rs4919510 polymorphism in miRNA-608 was associated with a decreased risk of collateral cancer (<xref ref-type="bibr" rid="B4">Dai et&#x20;al., 2018</xref>). <xref ref-type="bibr" rid="B18">L&#xf3;pez-L&#xf3;pez et&#x20;al. (2014)</xref> indicated significant associations between rs4919510 polymorphism in miRNA-608 and toxicity for cancer treatment (<xref ref-type="bibr" rid="B18">L&#xf3;pez-L&#xf3;pez et&#x20;al., 2014</xref>). <xref ref-type="bibr" rid="B2">Al-Qahtani et&#x20;al. (2017)</xref> found that miR-608 rs4919510 was associated with an increased risk of disease progression in patients with HBV (<xref ref-type="bibr" rid="B2">Al-Qahtani et&#x20;al., 2017</xref>). <xref ref-type="bibr" rid="B37">Zhang et&#x20;al. (2015)</xref> indicated that miR-608 rs4919510 was found to be strongly associated with a higher risk of developing sepsis and multiple organ dysfunction (<xref ref-type="bibr" rid="B37">Zhang et&#x20;al., 2015</xref>).</p>
<p>miRNA let-7 is involved in numerous cellular processes, inflammation, immunity, protective functions, and viral infections (<xref ref-type="bibr" rid="B3">Bernstein et&#x20;al., 2021</xref>). <xref ref-type="bibr" rid="B16">Li et&#x20;al. (2016)</xref> reported the relationship of the pri-let-7a-1 rs10739971 polymorphism with the prognosis of gastric cancer patients in northern China (<xref ref-type="bibr" rid="B16">Li et&#x20;al., 2016</xref>). <italic>M. tuberculosis</italic> suppresses the innate immune response in macrophages, when suppressing miRNA let-7f expression, and modulates the immune response to TB infection by elevating target expression, A20, an inhibitor of the NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B13">Kumar et&#x20;al., 2015</xref>).</p>
<p>
<xref ref-type="bibr" rid="B22">Ni et&#x20;al. (2014)</xref> and <xref ref-type="bibr" rid="B12">Kleinsteuber et&#x20;al. (2013)</xref> reported that <italic>M. tuberculosis</italic> can modulate the expression of host miRNA and limit the response of macrophages during TB infection. miRNA 26-A targets a component (P300) of the IFN-y signaling cascade and was found to be differently expressed during tuberculosis infection (<xref ref-type="bibr" rid="B12">Kleinsteuber et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B22">Ni et&#x20;al., 2014</xref>). miRNA-26a regulates innate immune signaling, macrophages polarization, and trafficking of <italic>Mycobacterium tuberculosis</italic> to lysosomes during TB infection (<xref ref-type="bibr" rid="B26">Sahu et&#x20;al., 2017</xref>). It also plays a role in intestinal inflammation (<xref ref-type="bibr" rid="B38">Zhang et&#x20;al., 2021</xref>), preeclampsia (<xref ref-type="bibr" rid="B7">Eskandari et&#x20;al., 2019</xref>), and cancer (<xref ref-type="bibr" rid="B36">Ying et&#x20;al., 2016</xref>).</p>
<p>Studies have shown that miRNA-100 is associated with the adaptive immune system (<xref ref-type="bibr" rid="B21">Negi et&#x20;al., 2015</xref>), anti-inflammatory function in the vascular system (<xref ref-type="bibr" rid="B23">Pankratz et&#x20;al., 2018</xref>), and the occurrence, development, and cancer invasion (<xref ref-type="bibr" rid="B17">Liu et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B9">Huang et&#x20;al., 2020</xref>). Genetic variation in miRNA-100 rs1834306 was found to be an increased risk of gastrointestinal disease (<xref ref-type="bibr" rid="B40">Zhu et&#x20;al., 2020</xref>), increased risk of Hepatitis B virus (<xref ref-type="bibr" rid="B19">Motawi et&#x20;al., 2019</xref>, 1834306), and a decreased risk for esophageal squamous cell carcinoma (<xref ref-type="bibr" rid="B39">Zhu et&#x20;al., 2015</xref>) in several studies.</p>
<p>
<xref ref-type="bibr" rid="B15">Li et&#x20;al. (2011)</xref> reported that there was no association between miR-499 rs3746444 and pulmonary tuberculosis (PTB) risk in the Han population; however, subjects carrying the C allele showed a decreased PTB risk. Li et&#x20;al. also found that there was an association between rs3746444 and PTB in the Tibetan population, and individuals carrying the C allele exhibited an increased PTB risk (<xref ref-type="bibr" rid="B15">Li et&#x20;al., 2011</xref>). <xref ref-type="bibr" rid="B20">Naderi et&#x20;al. (2015)</xref> indicated a lack of association between miRNA-146a rs2910164 and miRNA-499 rs3746444 gene polymorphisms and susceptibility to pulmonary tuberculosis (<xref ref-type="bibr" rid="B20">Naderi et&#x20;al., 2015</xref>). Additionally, miR-499 rs3746444 was related to other diseases, including acute lymphoblastic leukemia (<xref ref-type="bibr" rid="B5">de Souza et&#x20;al., 2020</xref>), asthma (<xref ref-type="bibr" rid="B6">Dong et&#x20;al., 2020</xref>, 49), and inflammatory arthritis (<xref ref-type="bibr" rid="B33">Wang and Pan 2019</xref>).</p>
<p>Studies have evaluated the association between the SNP miRNA-423 rs6505162 and susceptibility to colorectal carcinoma (<xref ref-type="bibr" rid="B11">Jia et&#x20;al., 2018</xref>) and coronary artery disease (<xref ref-type="bibr" rid="B10">Jha et&#x20;al., 2019</xref>). A recent study showed that the expression of miRNA-423 was significantly increased in the serum of patients with tuberculosis, and the upregulation of miR-423-5p could suppress autophagosome&#x2013;lysosome fusion in macrophages by posttranscriptional regulation of VPS33A (<xref ref-type="bibr" rid="B32">Tu et&#x20;al., 2019</xref>).</p>
</sec>
<sec id="s5">
<title>5 Conclusion</title>
<p>In this study, it was possible to determine the genotypic frequencies for the SNP in selected genes as well as associations related to risk or protection for tuberculosis infection. We found seven genetic variants significantly associated in individuals with tuberculosis from the Amazon region. Our study revealed that the SNPs rs10035440 (DROSHA), rs7372209 (miR26-a1), rs1834306 (miR100), rs4919510 (miR608), and rs10739971 (pri-let-7a-1) were significantly associated with a high risk of TB. In addition, the SNPs rs3746444 (miR499) and rs6505162 (miR423) were significantly associated with a low risk of developing tuberculosis. Our study contributes to a better understanding of TB pathogenesis and may promote the development of new diagnostic tools against <italic>M. tuberculosis</italic> infection. Future studies must be carried out to evaluate the functional effects of polymorphisms of the selected genes as well as the inclusion of other SNPs and large sample study, to corroborate the findings for tuberculosis in our country.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://figshare.com/">https://figshare.com/</ext-link>, <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.6084/m9.figshare.17954717.v2">https://doi.org/10.6084/m9.figshare.17954717.v2</ext-link>.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by N&#x00FA;cleo de Pesquisa em Oncologia/Universidade Federal do Par&#x00E1; (CAE n&#x00B0; 42106720.2.0000.5634). The patients/participants provided their written informed consent to participate in this&#x20;study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>NPCS, SEBS and PPA conceived and designed the experiments. DFVBL, AACM, DCRFP, CAS, and ASCA performed the experiments. MRF, LFP, MNSS analysed the data. DFVBL wrote the paper.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was financed in part by the Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior (CAPES), Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico&#x2013;CNPq (CNPq), and Pr&#xf3;-Reitoria de Pesquisa e P&#xf3;s-Gradua&#xe7;&#xe3;o (PROPESP/UFPA).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acharya</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghimire</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Parajuli</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Advances in Diagnosis of Tuberculosis: An Update into Molecular Diagnosis of <italic>Mycobacterium T</italic>
</article-title>. <source>Mol. Biol. Rep.</source> <volume>47</volume>, <fpage>4065</fpage>&#x2013;<lpage>4075</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-020-05413-7</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Qahtani</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Al-Anazi</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Nazir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abdo</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Sanai</surname>
<given-names>F. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Association of Single Nucleotide Polymorphisms in microRNAs with Susceptibility to Hepatitis B Virus Infection and HBV-Related Liver Complications: A Study in a Saudi Arabian Population</article-title>. <source>J.&#x20;Viral Hepat.</source> <volume>24</volume>, <fpage>1132</fpage>&#x2013;<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.1111/jvh.12749</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernstein</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Rom</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>let-7 microRNAs: Their Role in Cerebral and Cardiovascular Diseases, Inflammation, Cancer, and Their Regulation</article-title>. <source>Biomedicines</source> <volume>9</volume>, <fpage>606</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines9060606</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>J.-R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X.-M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The Role of microRNA-608 Polymorphism on the Susceptibility and Survival of Cancer: a Meta-Analysis</article-title>. <source>Aging</source> <volume>10</volume>, <fpage>1402</fpage>&#x2013;<lpage>1414</lpage>. <pub-id pub-id-type="doi">10.18632/aging.101476</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>de Carvalho</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Wanderley</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J.&#x20;C. G.</given-names>
</name>
<name>
<surname>Cohen-Paes</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Influence of Variants of the Drosha, Mir499a, and Mir938 Genes on Susceptibility to Acute Lymphoblastic Leukemia in an Admixed Population from the Brazilian Amazon</article-title>. <source>Am. J.&#x20;Transl Res.</source> <volume>12</volume>, <fpage>8216</fpage>&#x2013;<lpage>8224</lpage>. </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Association of Two Polymorphisms of miRNA-146a Rs2910164 (G &#x3e; C) and miRNA-499 Rs3746444 (T &#x3e; C) with Asthma: A Meta-Analysis</article-title>. <source>J.&#x20;Asthma</source> <volume>58</volume>, <fpage>995</fpage>&#x2013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1080/02770903.2020.1759085</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskandari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rezaei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mohammadpour-Gharehbagh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Teimoori</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yaghmaei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Narooei-Nejad</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The Association of Pri-miRNA- 26a1 Rs7372209 Polymorphism and Preeclampsia Susceptibility</article-title>. <source>Clin. Exp. Hypertens.</source> <volume>41</volume>, <fpage>268</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1080/10641963.2018.1469643</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutierrez-Camino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lopez-Lopez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Martin-Guerrero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pi&#xf1;an</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Garcia-Miguel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sanchez-Toledo</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Noncoding RNA-Related Polymorphisms in Pediatric Acute Lymphoblastic Leukemia Susceptibility</article-title>. <source>Pediatr. Res.</source> <volume>75</volume>, <fpage>767</fpage>&#x2013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2014.43</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>MicroRNA-100 Functions as a Tumor Suppressor in Cervical Cancer via Downregulating the SATB1 Expression and Regulating AKT/mTOR Signaling Pathway and Epithelial-to-mesenchymal Transition</article-title>. <source>Oncol. Lett.</source> <volume>20</volume>, <fpage>1336</fpage>&#x2013;<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2020.11686</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jha</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Mir</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Elfaki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Khullar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Javid</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery Disease</article-title>. <source>EMIDDT</source> <volume>19</volume>, <fpage>67</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.2174/1871530318666181005095724</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Association of microRNA-423 Rs6505162 C&#x3e;A Polymorphism with Susceptibility and Metastasis of Colorectal Carcinoma</article-title>. <source>Medicine</source> <volume>97</volume>, <fpage>e9846</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000009846</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinsteuber</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Heesch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schattling</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kohns</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sander-J&#xfc;lch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Walzl</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4&#x207a; T&#x20;Cells and Peripheral Blood from Tuberculosis Patients</article-title>. <source>PLoS ONE</source> <volume>8</volume>, <fpage>e61609</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061609</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Subuddhi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maji</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Jana</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>MicroRNA Let-7 Modulates the Immune Response to <italic>Mycobacterium T</italic> Infection via Control of A20, an Inhibitor of the NF-&#x39a;b Pathway</article-title>. <source>Cell Host Microbe</source> <volume>17</volume>, <fpage>345</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.01.007</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leal</surname>
<given-names>D. F. D. V. B.</given-names>
</name>
<name>
<surname>Santana da Silva</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>D. C. R. D. O.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J.&#x20;C. G.</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>M. C. D. C.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>P. D. D. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Amerindian Genetic Ancestry as a Risk Factor for Tuberculosis in an Amazonian Population</article-title>. <source>PLoS One</source> <volume>15</volume>, <fpage>e0236033</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0236033</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qucuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Genetic Study of Two Single Nucleotide Polymorphisms within Corresponding microRNAs and Susceptibility to Tuberculosis in a Chinese Tibetan and Han Population</article-title>. <source>Hum. Immunol.</source> <volume>72</volume>, <fpage>598</fpage>&#x2013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2011.03.004</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Pri-let-7a-1 Rs10739971 Polymorphism Is Associated with Gastric Cancer Prognosis and Might Affect Mature Let-7a Expression</article-title>. <source>Onco Targets Ther.</source> <volume>9</volume>, <fpage>3951</fpage>&#x2013;<lpage>3962</lpage>. <pub-id pub-id-type="doi">10.2147/OTT.S100481</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>K.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.-L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.-X.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>MicroRNA-100 Is a Potential Molecular Marker of Non-Small Cell Lung Cancer and Functions as a Tumor Suppressor by Targeting Polo-Like Kinase 1</article-title>. <source>BMC Cancer</source> <volume>12</volume>, <fpage>519</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-12-519</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez-L&#xf3;pez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Guti&#xe9;rrez-Camino</surname>
<given-names>&#xc1;.</given-names>
</name>
<name>
<surname>Pi&#xf1;&#xe1;n</surname>
<given-names>M. &#xc1;.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Toledo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Uriz</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Ballesteros</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>3</issue>), <fpage>e91261</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0091261</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motawi</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Mady</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Shaheen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Elshenawy</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Talaat</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Rizk</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Genetic Variation in microRNA-100 (miR-100) Rs1834306&#x20;T/C Associated with Hepatitis B Virus (HBV) Infection: Correlation with Expression Level</article-title>. <source>Infect. Genet. Evol.</source> <volume>73</volume>, <fpage>444</fpage>&#x2013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2019.06.009</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naderi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashemi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khorgami</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Koshki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ebrahimi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amininia</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Lack of Association between miRNA-146a Rs2910164 and miRNA-499 Rs3746444 Gene Polymorphisms and Susceptibility to Pulmonary Tuberculosis</article-title>. <source>Int. J.&#x20;Mol. Cel Med</source> <volume>4</volume>, <fpage>40</fpage>&#x2013;<lpage>45</lpage>. </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bajpai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Altered Expression and Editing of miRNA-100 Regulates iTreg Differentiation</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume>, <fpage>8057</fpage>&#x2013;<lpage>8065</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv752</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rajaram</surname>
<given-names>M. V. S.</given-names>
</name>
<name>
<surname>Lafuse</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Landes</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>Mycobacterium T</italic> Decreases Human Macrophage IFN-&#x3b3; Responsiveness through miR-132 and miR-26a</article-title>. <source>J.&#x20;Immunol.</source> <volume>193</volume>, <fpage>4537</fpage>&#x2013;<lpage>4547</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1400124</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pankratz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hohnloser</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bemtgen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jaenich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kreuzaler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hoefer</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy</article-title>. <source>Circ. Res.</source> <volume>122</volume>, <fpage>417</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311428</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos</surname>
<given-names>B. R. D. A.</given-names>
</name>
<name>
<surname>D&#x2019;Elia</surname>
<given-names>M. P. B.</given-names>
</name>
<name>
<surname>Amador</surname>
<given-names>M. A. T.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>N. P. C.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>S. E. B.</given-names>
</name>
<name>
<surname>da Cruz Castelli</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Neither self-Reported Ethnicity Nor Declared Family Origin Are Reliable Indicators of Genomic Ancestry</article-title>. <source>Genetica</source> <volume>144</volume>, <fpage>259</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1007/s10709-016-9894-1</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. Z. A.</given-names>
</name>
<name>
<surname>Peramo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <fpage>602</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.00602</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahu</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBP&#x3b2; Regulate Innate Immune Signaling, the Polarization of Macrophages and the Trafficking of <italic>Mycobacterium T</italic> to Lysosomes during Infection</article-title>. <source>Plos Pathog.</source> <volume>13</volume>, <fpage>e1006410</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006410</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>N. P. C.</given-names>
</name>
<name>
<surname>Ribeiro-Rodrigues</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Ribeiro-dos-Santos</surname>
<given-names>&#xc2;. K. C.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gusm&#xe3;o</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Amorim</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Assessing Individual Interethnic Admixture and Population Substructure Using a 48-Insertion-Deletion (INSEL) Ancestry-Informative Marker (AIM) Panel</article-title>. <source>Hum. Mutat.</source> <volume>31</volume>, <fpage>184</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21159</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>D. C. R. O.</given-names>
</name>
<name>
<surname>Braga</surname>
<given-names>A. C. O.</given-names>
</name>
<name>
<surname>Cavalcante</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Sortica</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Hutz</surname>
<given-names>M. H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Investigation of Genetic Susceptibility to <italic>Mycobacterium T</italic> (VDR and IL10 Genes) in a Population with a High Level of Substructure in the Brazilian Amazon Region</article-title>. <source>Int. J.&#x20;Infect. Dis.</source> <volume>98</volume>, <fpage>447</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.06.090</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Ribeiro-dos-Santos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pantoja</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Vinasco-Sandoval</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Can miRNA Indicate Risk of Illness after Continuous Exposure to <italic>M. T</italic>?</article-title> <source>Int. J.&#x20;Mol. Sci.</source> <volume>22</volume>, <fpage>3674</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22073674</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>QuCuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Association between SNPs in microRNA-Machinery Genes and Tuberculosis Susceptibility in Chinese Tibetan Population</article-title>. <source>Mol. Biol. Rep.</source> <volume>40</volume>, <fpage>6027</fpage>&#x2013;<lpage>6033</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-013-2712-2</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamgue</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gcanga</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ozturk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pillay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Differential Targeting of C-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of <italic>Mycobacterium T</italic> in Alternatively IL-4/IL-13 Activated Macrophages</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>421</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00421</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Elevated Pulmonary Tuberculosis Biomarker miR-423-5p Plays Critical Role in the Occurrence of Active TB by Inhibiting Autophagosome-Lysosome Fusion</article-title>. <source>Emerging Microbes Infections</source> <volume>8</volume>, <fpage>448</fpage>&#x2013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1080/22221751.2019.1590129</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Association of Rs2910164 Polymorphism in miRNA-146 and Rs3746444 Polymorphism in miRNA-499 with Inflammatory Arthritis: A Meta-Analysis</article-title>. <source>Biomed. Res. Int.</source> <volume>2019</volume>, <fpage>7305750</fpage>. <pub-id pub-id-type="doi">10.1155/2019/7305750</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Specific Roles of MicroRNAs in Their Interactions with Environmental Factors</article-title>. <source>J.&#x20;Nucleic Acids</source> <volume>2012</volume>, <fpage>978384</fpage>. <pub-id pub-id-type="doi">10.1155/2012/978384</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<collab>WHO</collab> (<year>2020</year>). <article-title>Global Tuberculosis Report 2020</article-title>. <comment>Global tuberculosis report 2020 Genebra</comment>. </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying</surname>
<given-names>H.-Q.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.-X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B.-S.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.-Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>MiR-608, Pre-miR-124-1 and Pre-miR26a-1 Polymorphisms Modify Susceptibility and Recurrence-free Survival in Surgically Resected CRC Individuals</article-title>. <source>Oncotarget</source> <volume>7</volume>, <fpage>75865</fpage>&#x2013;<lpage>75873</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.12422</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>A.-Q.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.-Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>D.-Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Genetic Variants of microRNA Sequences and Susceptibility to Sepsis in Patients with Major Blunt Trauma</article-title>. <source>Ann. Surg.</source> <volume>261</volume>, <fpage>189</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1097/SLA.0000000000000687</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>miR-26a Attenuates Colitis and Colitis-Associated Cancer by Targeting the Multiple Intestinal Inflammatory Pathways</article-title>. <source>Mol. Ther. - Nucleic Acids</source> <volume>24</volume>, <fpage>264</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2021.02.029</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Genetic Variation in miR-100 Rs1834306 Is Associated with Decreased Risk for Esophageal Squamous Cell Carcinoma in Kazakh Patients in Northwest China</article-title>. <source>Int. J.&#x20;Clin. Exp. Pathol.</source> <volume>8</volume>, <fpage>7332</fpage>&#x2013;<lpage>7340</lpage>. </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>miR-100 Rs1834306 A&#x3e;G Increases the Risk of Hirschsprung Disease in Southern Chinese Children</article-title>. <source>PGPM</source> <volume>13</volume>, <fpage>283</fpage>&#x2013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.2147/PGPM.S265730</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>